Quantcast

Latest Ribbon symbolism Stories

2014-07-30 23:16:03

TeVido BioDevices, developer of 3d bioprinted grafts for use in breast reconstruction, announced as one of 20 semifinalists Austin, Texas (PRWEB) July 30, 2014 TeVido BioDevices was selected as one of 20 entries to move onto the Martha and Kozo Shimano Entrepreneur Accelerator Program phase of the LIVESTRONG Foundation’s Big C competition, aiming to change the way the world lives with cancer. TeVido BioDevices will now be vying for one of five spots in the contest’s final round,...

2014-07-30 08:33:06

Studies Support Ongoing Clinical Strategy of Using Syndax's Entinostat as Epigenetic Priming to Immune Therapy WALTHAM, Mass., July 30, 2014 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. today announced that newly published results demonstrate that in preclinical studies entinostat significantly improved treatment outcomes in mouse tumor models when combined with anti-PD1 and anti-CTLA4 targeted antibodies. The paper from Kim, et al. at The Sidney Kimmel Comprehensive Cancer Center,...

2014-07-29 08:31:57

Gamma Medica meets the global demands of breast imaging by providing high sensitivity and specificity MOUNTAIN VIEW, Calif., July 29, 2014 /PRNewswire/ -- Based on its recent analysis of the breast imaging systems market, Frost & Sullivan recognizes Gamma Medica with the 2014 Global Frost & Sullivan Award for Product Leadership. Gamma Medica's LumaGEM Molecular Breast Imaging (MBI) system provides breast images through the digital direct conversion of photons in gamma rays into...

2014-07-29 04:22:01

ROCKLAND, Massachusetts, July 29, 2014 /PRNewswire/ -- - First patient begins treatment in an international Phase II study investigating the efficacy and safety of MSB0010718C in patients with metastatic Merkel cell carcinoma (mMCC) - mMCC is a rare and aggressive skin cancer lacking effective treatments - MSB0010718C is also currently being explored in a seven cohort Phase I clinical trial for the treatment of solid...

2014-07-28 23:11:58

Health and wellness company, HealthFair, has been accredited in the Mammography Accreditation Program for their mobile health centers. Orlando, FL (PRWEB) July 28, 2014 The American College of Radiology has accredited HealthFair in the Mammography Accreditation Program which is a requirement for all U.S. facilities. This program provides peer review and feedback on staff qualifications, equipment, quality control and assurance, image quality and dose. It is the largest accreditation...

2014-07-28 23:01:12

Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in the U.S. die each year from metastatic breast and prostate cancers – an aggressive form of the disease that occurs when the cancer has spread to other parts of the body, such as the lungs, liver, bones, or brain. Now researchers at Drexel University College of Medicine have developed a compound directed at a target they identified that...

2014-07-28 08:29:21

Researchers: Automated Measurement of Volumetric Mammographic Density is a Promising Tool for Widespread Breast Cancer Risk Assessment WELLINGTON, New Zealand, July 28, 2014 /PRNewswire/ -- A prospective study conducted by the Karolinska Institute in Sweden has validated the performance of VolparaDensity breast imaging software across multiple vendor platforms and has associated volumetrically assessed breast density measurements to breast cancer risk. Published in Cancer...

2014-07-24 23:05:03

The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. Bethesda, MD (PRWEB) July 24, 2014 The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. This is an...

2014-07-24 08:33:56

ThermoDox® Continues to Demonstrate Impressive Local Response Rate in Refractory Patients LAWRENCEVILLE, N.J., July 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in Recurrent Chest Wall Breast Cancer (RCWBC). The trial is designed to enroll 20 patients at several U.S. clinical sites and is evaluating ThermoDox in combination with mild hyperthermia. Of the 13 patients...

2014-07-23 23:18:30

Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Albany, New York (PRWEB) July 22, 2014 According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs)...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related